SCOPUS 정보 검색 플랫폼

Volumn 102, Issue 5, 2010, Pages 940-

Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; PANITUMUMAB; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

COLORECTAL CANCER; HUMAN; LETTER; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; COLORECTAL NEOPLASMS; HUMANS; META-ANALYSIS AS TOPIC; PROGNOSIS; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 77649273768 PISSN: 00070920 EISSN: 15321827 Source Type: Journal
DOI: 10.1038/sj.bjc.6605575 Document Type: Letter

Times cited : (33)

References (4)

1
- 35348908314
- PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients
- Frattini M, Saletti P, Romagnani E, Martin V, Molinari F, Ghisletta M, Camponovo A, Etienne LL, Cavalli F, Mazzucchelli L (2007) PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients. Br J Cancer 97: 1139-1145
- (2007) Br J Cancer , vol.97 , pp. 1139-1145
- Frattini, M.¹ Saletti, P.² Romagnani, E.³ Martin, V.⁴ Molinari, F.⁵ Ghisletta, M.⁶ Camponovo, A.⁷ Etienne, L.L.⁸ Cavalli, F.⁹ Mazzucchelli, L.¹⁰

2
- 66849140563
- PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer
- Loupakis F, Pollina L, Stasi I, Ruzzo A, Scartozzi M, Santini D, Masi G, Graziano F, Cremolini C, Rulli E, Canestrari E, Funel N, Schiavon G, Petrini I, Magnani M, Tonini G, Campani D, Floriani I, Cascinu S, Falcone A (2009) PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer. J Clin Oncol 27: 2622-2629
- (2009) J Clin Oncol , vol.27 , pp. 2622-2629
- Loupakis, F.¹ Pollina, L.² Stasi, I.³ Ruzzo, A.⁴ Scartozzi, M.⁵ Santini, D.⁶ Masi, G.⁷ Graziano, F.⁸ Cremolini, C.⁹ Rulli, E.¹⁰ Canestrari, E.¹¹ Funel, N.¹² Schiavon, G.¹³ Petrini, I.¹⁴ Magnani, M.¹⁵ Tonini, G.¹⁶ Campani, D.¹⁷ Floriani, I.¹⁸ Cascinu, S.¹⁹ Falcone, A.²⁰ more..

3
- 63949084084
- Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant
- Molinari F, Martin V, Saletti P, De Dosso S, Spitale A, Camponovo A, Bordoni A, Crippa S, Mazzucchelli L, Frattini M (2009) Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant. Br J Cancer 100: 1087-1094
- (2009) Br J Cancer , vol.100 , pp. 1087-1094
- Molinari, F.¹ Martin, V.² Saletti, P.³ De Dosso, S.⁴ Spitale, A.⁵ Camponovo, A.⁶ Bordoni, A.⁷ Crippa, S.⁸ Mazzucchelli, L.⁹ Frattini, M.¹⁰

4
- 62449302407
- PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies
- Sartore-Bianchi A, Martini M, Molinari F, Veronese S, Nichelatti M, Artale S, Di Nicolantonio F, Saletti P, De Dosso S, Mazzucchelli L, Frattini M, Siena S, Bardelli A (2009) PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies. Cancer Res 69: 1851-1857
- (2009) Cancer Res , vol.69 , pp. 1851-1857
- Sartore-Bianchi, A.¹ Martini, M.² Molinari, F.³ Veronese, S.⁴ Nichelatti, M.⁵ Artale, S.⁶ Di Nicolantonio, F.⁷ Saletti, P.⁸ De Dosso, S.⁹ Mazzucchelli, L.¹⁰ Frattini, M.¹¹ Siena, S.¹² Bardelli, A.¹³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.